User menu

Moclobemide versus fluoxetine for a major depressive episode.

Bibliographic reference Reynaert, Christine ; Parent, M. ; Mirel, J ; Janne, Pascal ; Haazen, L.. Moclobemide versus fluoxetine for a major depressive episode.. In: Psychopharmacology, Vol. 118, no. 2, p. 183-7 (1995)
Permanent URL
  1. Amrein R, Güntert TW, Dingemanse J, Lorscheid T, Stabl M, Schmid-Burgk (1992) Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies. Psychopharmacology 106:S24-S31
  2. Baier D, Philipp M (1994) Effects of antidepressants on sexual function. Fortschr Neurol Psychiatr 62:14–20
  3. Bakish D, Bradwejn J, Nair N, McClure J, Remick R, Bulger L (1992) A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study. Psychopharma-cology 106:S98-S101
  4. Balon R, Vikram K, Yeragani V, Pohl R, Ramesh C (1993) Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 54:209–212
  5. Baumhackl U, Bizière K, Fischbach R (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM III): an Austrian double-blind, multicentre study. Br J Psychiatry 155, [suppl. 6]:78–83
  6. Burkard WP, Bonetti EP, Da Prada M, Martin JR, Polc P, Schaffner R, Scherschlicht R, Hefti F, Müller RKM, Wyss PC, Haefely W (1989) Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 248:391–399
  7. Chen DT, Ruch R (1993) Safety of moclobemide in clinical use. Clin Neuropharmacol 16[suppl. 2]:S63-S68
  8. Geerts S., Bruynooghe F., De Cuyper H., Demeulemeester F., Haazen L., Moclobemide Versus Fluoxetine for Major Depressive Episodes : , 10.1097/00002826-199417001-00007
  9. Guelfi JD, Payan C, Fermanian J, Pedarriosse A-M, Manfredi R (1992) Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial. Br J Psychiatry 160:519–524
  10. Louie AK, Lewis TB, Lannon RA (1993) Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 54:435–438
  11. Montgomery SA (1989) The efficacy of fluoxetine as an antidepressant in the short and long term. Int Clin Psychopharmacol 4[suppl. 1]:113–119
  12. Pande AC, Sayler ME (1993) Adverse events and treatment discontinuations in fluoxetine clinical trials. Int Clin Psychopharmacol 8:267–269
  13. Patterson WM (1993) Fluoxetine-induced sexual dysfunction (letter). J Clin Psychiatry 54:71
  14. Philipp M, Kohnen R, Benkert O (1993) A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 7:149–153
  15. Silverstone T (1993) Moclobemide—placebo-controlled trals. Int Clin Psychopharmacol 7:133–136
  16. Versiani M, Oggero U, Alterwain R, Capponi R, Dajas F, Heinze-Martin G, Marquez CA, Poleo MA, Rivero-Alzmanor LE, Rossel L, Schmid-Burgk W, Ucha Udabe R (1989) A double-blind comparative trial of moclobemide versus imipramine and placebo in major depressive episodes. Br J Psychiatry 155[suppl. 6]:72–77
  17. Versiani M, Nardi AE, Figueira ILV, Stabl M (1990) Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Acta Psychiatr Scand Suppl. 360:24–28
  18. Wernicke JF, Dunlop SR, Dornseif BE, Bosomworth JC, Humbert M (1988) Low-dose fluoxetine therapy for depression. Psychopharmacol Bull 24 [1]:183–188
  19. Wernicke JF, Janet C, Bosomworth, Ashbrook E (1989) Fluoxetine at 20 mg per day: the recommended and therapeutic dose in the treatment of depression. Int Clin Psychopharmacol 4 [suppl. 1]:63–67
  20. Williams R, Edwards RA, Newburn GM, Mullen R, Menkes DB, Segkar C (1993) A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders. Int Clin Psychopharmacol 7:155–158